Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo

Journal of Virology

Volumn 77, Issue 15, 2003, Pages 8249-8255

  Cicin Sain, Luka ^a   Brune, Wolfram ^b   Bubic, Ivan ^c   Jonjic, Stipan ^c   Koszinowski, Ulrich H ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; NUCLEIC ACID; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CLONE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA VECTOR; ESCHERICHIA COLI; FIBROBLAST; GENE EXPRESSION; HERPES VIRUS; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; VACCINATION; VIRUS GENOME; VIRUS REPLICATION;

EID: 0038447940     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.15.8249-8255.2003     Document Type: Article

References (42)

1. Adler, H., M. Messerle, M. Wagner, and U. H. Koszinowski. 2000. Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 74:6964-6974.
2. Borst, E. M., G. Hahn, U. H. Koszinowski, and M. Messerle. 1999 Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73:8320-8329.
3. Brune, W., M. Hasan, M. Krych, I. Bubic, S. Jonjic, and U. H. Koszinowski. 2001. Secreted virus-encoded proteins reflect murine cytomegalovirus productivity in organs. J. Infect. Dis, 184:1320-1324.
4. Brune, W., H. Hengel, and U. H. Koszinowski. 1999. A mouse model for cytomegalovirus infection, p. 19.7.1-19.7.13. In J. Coligan, A. Kruisbeen, D. Marguiles, E. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley, New York, N.Y.
5. Brune, W., C. Menard, J. Heesemann, and U. H. Koszinowski. 2001. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291:303-305.
6. Brune, W., C. Menard, U. Hobom, S. Odenbreit, M. Messerle, and U. H. Koszinowski. 1999. Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nat. Biotechnol. 17:360-364.
7. Buchmeier, N. A., C. J. Lipps, M. Y. So, and F. Heffron. 1993. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol. Microbiol. 7:933-936.
8. + gene product is more important than catalase and superoxide dismutase in protecting Escherichia coli against hydrogen peroxide toxicity. J. Bacteriol. 142:319-321.
9. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548-551.
10. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes, Science 259:1739-1742.
11. Darji, A., C. A. Guzman, B. Gerstel, P. Wachholz, K. N. Timmis, J. Wehland, T. Chakraborty, and S. Weiss. 1997. Oral somatic transgene vaccination using attenuated S. enterica serovar Typhimurium. Cell 91:765-775.
12. Dubensky, T. W., B. A. Campbell, and L. P. Villarreal. 1984. Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc. Natl. Acad. Sci. USA 81:7529-7533.
13. Fennelly, G. J., S. A. Khan, M. A. Abadi, T. F. Wild, and B. R. Bloom. 1999. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol. 162:1603-1610.
14. Garcia-del Portillo, F. 2001. Salmonella intracellular proliferation: where, when and how? Microbes Infect. 3:1305-1311.
15. Goldberg, M., L. S. Belkowski, and B. R. Bloom. 1990. Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene. J. Clin. Investig. 85:563-569.
16. Gonzalez-Armas, J. C., C. S. Morello, L. D. Cranmer, and D. H. Spector. 1996. DNA immunization confers protection against murine cytomegalovirus infection. J. Virol. 70:7921-7928.
17. Grillot-Courvalin, C., S. Goussard, F. Huetz, D. M. Ojcius, and P. Courvalin. 1998. Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 16:862-866.
18. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
19. Janeway, C. A., and P. Travers. 1997. Immunobiology: the immune system in health and disease, 3rd ed. Current Biology, Ltd./ arland Publisihng, Inc., New York, N.Y.
20. Jonjic, S., M. del Val, G. M. Keil, M. J. Reddehase, and U. H. Koszinowski. 1988. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J. Virol. 62:1653-1658.
21. Kamijo, R., D. Shapiro, J. Le, S. Huang, M. Aguet, and J. Vilcek. 1993. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc. Natl. Acad. Sci. USA 90:6626-6630.
22. MacDonald, M. R., X. Y. Li, R. M. Stenberg, A. E. Campbell, and H. W. t. Virgin. 1998. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant. J. Virol. 72:442-451.
23. Medina, E., and C. A. Guzman. 2001. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19:1573-1580.
24. Messerle, M., I. Crnkovic, W. Hammerschmidt, H. Ziegler, and U. H. Koszinowski. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA 94:14759-14763.
25. Mocarski, E. S., and C. T. Courcelle. 2001. Cytomegaloviruses and their replication, p. 2629-2673. In D. Knipe and P. Howley (ed.), Fields virology, 4th ed. Lippincott-Raven, Philadelphia, Pa.
26. Morello, C. S., M. Ye, and D. H. Spector. 2002. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. J. Virol. 76:4822-4835.
27. Nathan, C. F., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670-689.
28. Paglia, P., E. Medina, I. Arioli, C. A. Guzman, and M. P. Colombo. 1998. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92:3172-3176.
29. Poirier, T. P., M. A. Kehoe, and E. H. Beachey. 1988. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J. Exp. Med. 168:25-32.
30. Presti, R. M., J. L. Pollock, A. J. Dal-Canto, A. K. O'Guin, and H. W. Virgin. 1998. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577-588.
31. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
32. Reddehase, M. J., F. Weiland, K. Munch, S. Jonjic, A. Luske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264-273.
33. Richter-Dahlfors, A., A. M. Buchan, and B. B. Finlay. 1997. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J. Exp. Med. 186:569-580.
34. Smith, G. R., S. M. Kunes, D. W. Schultz, A. Taylor, and K. L. Triman. 1981. Structure of chi hotspots of generalized recombination. Cell 24:429-436.
35. Suter, M., A. M. Lew, P. Grob, G. J. Adema, M. Ackermann, K. Shortman, and C. Fraefel. 1999. BAC-VAC, a novel generation of (DNA) vaccines: a bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 96:12697-12702.
36. Tischer, B. K., D. Schumacher, M. Beer, J. Beyer, J. P. Teifke, K. Osterrieder, K. Wink, V. Zelnik, F. Fehler, and N. Osterrieder. 2002. A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. J. Gen. Virol. 83:2367-2376.
37. Wagner, M., S. Jonjlc, U. H. Koszinowski, and M. Messerle. 1999. Syst. excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
38. Welsh, R. M., J. O. Brubaker, M. Vargas-Cortes, and C. L. O'Donnell. 1991. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 173:1053-1063.
39. Whitley, R. J., and B. Roizman. 2002. Herpes simplex viruses: is a vaccine tenable? J. Clin. Investig. 110:145-151.
40. Will, H., R. Cattaneo, G. Darai, F. Deinhardt, H. Schellekens, and H. Schaller. 1985. Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc. Natl. Acad. Sci. USA 82:891-895.
41. Will, H., R. Cattaneo, H. G. Koch, G. Darai, H. Schaller, H. Schellekens, P. M. van Eerd, and F. Deinhardt. 1982. Cloned HBV DNA causes hepatitis in chimpanzees. Nature 299:740-742.
42. Ye, M., C. S. Morello, and D. H. Spector. 2002. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge. J. Virol. 76:2100-2112.